NLRP3 inflammasome activation and its crosstalk with RLR signaling at the mitochondria
NLRP3 炎症小体激活及其与线粒体 RLR 信号传导的串扰
基本信息
- 批准号:10430234
- 负责人:
- 金额:$ 45.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-15 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinAutoimmune DiseasesBioenergeticsBiological AssayCASP1 geneCellsChemicalsCommunicable DiseasesComplementComplexCrystallizationDataDetectionFluorescenceFluorescence MicroscopyFunctional disorderGenerationsGoalsIRF3 geneInfectionInflammasomeInflammation MediatorsInterferon-betaInterferonsInterleukin-1 betaInterleukin-18InvestigationKnock-outLinkLocationMass Spectrum AnalysisMediatingMembraneMetabolic DiseasesMetabolic dysfunctionMitochondriaMitochondrial ProteinsModelingMusN-terminalNigericinOrganellesOuter Mitochondrial MembranePathway interactionsPhasePhysiologicalPlayProductionProteinsRNARNA Virus InfectionsRNA VirusesReceptor SignalingResolutionRoleSendai virusSignal PathwaySignal TransductionSiteSolidStimulusStructureToxinUrateVirus DiseasesX-Ray Tomographyautoinflammatorycrystallinitycytokineinsightmouse modelmutantperoxisomereceptorrecruitresponsesensorviral RNAviral detection
项目摘要
Project Summary
NLRP3 (NOD-Like Receptor Protein 3) is an intracellular sensor that detects a variety of stimuli including
infection and metabolic dysfunction resulting in assembly of a macromolecular signaling complex called the
inflammasome which promotes caspase-1 dependent processing of the cytokines IL-1b and IL-18 to their
bioactive forms; these cytokines in turn underlie the pathophysiology of many autoinflammatory, autoimmune,
metabolic and infectious diseases. NLRP3 is activated by a wide-range of molecules including monosodium
urate crystals, viral RNA and even bacterial pore-forming toxins, but little is known about the mechanisms by
which NLRP3 senses and elicits a response to these chemically and structurally dissimilar stimuli. We and
others have previously shown that NLRP3 associates with mitochondria upon activation. Whether this link
simply points to a requirement for a membrane platform to achieve efficient solid-phase assembly of
inflammasome signaling components or an active modulation of NLRP3 activation by mitochondrial
components or even mitochondrial proteins remains ambiguous. It is also unclear if and how interaction of
NLRP3 with mitochondria influences mitochondrial functions. We have previously shown that NLRP3
mitochondrial recruitment and the ensuing inflammasome response is dependent on interaction of a short N-
terminal sequence in NLRP3 with the outer mitochondrial adapter protein MAVS. However, MAVS specifically
augments inflammasome assembly in response to non-crystalline, but not crystalline NLRP3 activators
suggesting an interesting and complex mechanism by which mitochondria regulate NLRP3 inflammasome
activation. In this study, we propose that additional mitochondrial proteins control NLRP3 inflammasome
activation in response to different activators, conceivably in a stimulus-specific manner. In response to
detection of RNA viruses MAVS is engaged not only by NLRP3 but also by the RIG-I- like receptors (RLRs) to
produce type 1 interferons, suggesting an unexpected crosstalk between the NLRP3 and RLR signaling
pathways. In this proposal, we will elucidate the mechanisms by which mitochondria/MAVS regulate NLRP3
activation and examine its crosstalk with the RLR pathway. This will be accomplished by: 1) mass
spectrometry to identify additional mitochondrial proteins that associate with inflammasome complexes in
response to crystals and non-crystalline NLRP3 activators, followed by assays to evaluate their effect on
inflammasome activation and mitochondrial functions, 2) soft X-ray tomography and correlative fluorescence
microscopy to assess a requirement for subcellular membrane platforms in inflammasome assembly, and 3)
models of viral infection to identify the physiological consequences of MAVS-dependent crosstalk between the
NLRP3 and RLR pathways. These investigations will yield important mechanistic insights into how
mitochondria and MAVS regulate NLRP3 inflammasome activation, which may be of relevance for modulation
of NLRP3 activity not only in viral infections but also in a variety of metabolic diseases.
项目摘要
NLRP 3(NOD样受体蛋白3)是一种细胞内传感器,其检测多种刺激,包括
感染和代谢功能障碍导致大分子信号传导复合物的组装,
炎性小体,其促进细胞因子IL-1b和IL-18的半胱天冬酶-1依赖性加工,
生物活性形式;这些细胞因子又是许多自身炎症,自身免疫,
代谢和传染病。NLRP 3被广泛的分子激活,包括
尿酸盐晶体,病毒RNA,甚至细菌的成孔毒素,但很少有人知道的机制,
其中NLRP 3感知并激发对这些化学和结构上不同的刺激的响应。我们和
其他人先前已经表明NLRP 3在激活时与线粒体结合。无论这个链接
简单地指出了对膜平台的要求,以实现有效的固相组装,
炎症体信号传导组分或线粒体对NLRP 3活化的主动调节
组成部分,甚至线粒体蛋白质仍然是模糊的。目前还不清楚是否以及如何相互作用,
NLRP 3与线粒体一起影响线粒体功能。我们之前已经表明,NLRP 3
线粒体募集和随后的炎性小体反应依赖于短N-
NLRP 3的末端序列与外部线粒体衔接蛋白MAVS。然而,MAVS特别
响应于非结晶而非结晶NLRP 3活化剂而增强炎性小体组装
提示线粒体调节NLRP 3炎性体的有趣和复杂的机制
activation.在这项研究中,我们提出了额外的线粒体蛋白控制NLRP 3炎性体,
可以想象的是,以刺激特异性的方式响应于不同的激活剂的激活。响应于
RNA病毒的检测MAVS不仅与NLRP 3有关,而且与RIG-I样受体(RLR)有关,
产生1型干扰素,表明NLRP 3和RLR信号之间存在意外串扰
路径。在这个建议中,我们将阐明线粒体/MAVS调节NLRP 3的机制,
激活并检查其与RLR途径的串扰。这将通过以下方式实现:1)质量
光谱法鉴定与炎性小体复合物相关的其他线粒体蛋白,
对晶体和非晶体NLRP 3激活剂的反应,然后进行测定以评估其对
炎性小体激活和线粒体功能,2)软X射线断层扫描和相关荧光
显微镜以评估炎性小体组装中对亚细胞膜平台的需求,以及3)
病毒感染的模型,以确定MAVS依赖的串扰之间的生理后果,
NLRP 3和RLR通路。这些调查将产生重要的机械见解如何
线粒体和MAVS调节NLRP 3炎性小体活化,这可能与调节
NLRP 3活性不仅在病毒感染中,而且在多种代谢疾病中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Naeha Subramanian其他文献
Naeha Subramanian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Naeha Subramanian', 18)}}的其他基金
Host innate immune mechanisms control temporal expression of flagellin by pathogenic Salmonella
宿主先天免疫机制控制致病性沙门氏菌鞭毛蛋白的瞬时表达
- 批准号:
10299579 - 财政年份:2021
- 资助金额:
$ 45.75万 - 项目类别:
Does post-transcriptional control of NLRP3 inflammasome activity impact development of type 1 diabetes?
NLRP3 炎性体活性的转录后控制是否会影响 1 型糖尿病的发展?
- 批准号:
10158125 - 财政年份:2021
- 资助金额:
$ 45.75万 - 项目类别:
NLRP3 inflammasome activation and its crosstalk with RLR signaling at the mitochondria
NLRP3 炎症小体激活及其与线粒体 RLR 信号传导的串扰
- 批准号:
10626119 - 财政年份:2021
- 资助金额:
$ 45.75万 - 项目类别:
Host innate immune mechanisms control temporal expression of flagellin by pathogenic Salmonella
宿主先天免疫机制控制致病性沙门氏菌鞭毛蛋白的瞬时表达
- 批准号:
10426346 - 财政年份:2021
- 资助金额:
$ 45.75万 - 项目类别:
NLRP3 inflammasome activation and its crosstalk with RLR signaling at the mitochondria
NLRP3 炎症小体激活及其与线粒体 RLR 信号传导的串扰
- 批准号:
10280188 - 财政年份:2021
- 资助金额:
$ 45.75万 - 项目类别:
Does post-transcriptional control of NLRP3 inflammasome activity impact development of type 1 diabetes?
NLRP3 炎性体活性的转录后控制是否会影响 1 型糖尿病的发展?
- 批准号:
10404093 - 财政年份:2021
- 资助金额:
$ 45.75万 - 项目类别:
Host innate immune mechanisms control temporal expression of flagellin by pathogenic Salmonella
宿主先天免疫机制控制致病性沙门氏菌鞭毛蛋白的瞬时表达
- 批准号:
10636626 - 财政年份:2021
- 资助金额:
$ 45.75万 - 项目类别:
相似国自然基金
口腔疾病综合防治和关键技术研究-基于人工智能的口腔黏膜自身免疫性疾病筛查标志物与诊断体系的创建及相关产品研发
- 批准号:2025C02099
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
自身免疫性疾病的药物靶点发现及候选新药研究
- 批准号:RG25H310001
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
自身免疫性疾病中CyclingT细胞的增殖调控机制及其在疾病发生发展过程中的功能研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:青年科学基金项目
鄂产金丝桃属民族药治疗自身免疫性疾病物质基础的研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
索拉非尼通过诱导调节性T细胞抑制自身免疫性疾病的研究
- 批准号:32370955
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
核苷酸转移酶cGAS乙酰化修饰抑制剂的设计、合成及抗自身免疫性疾病的机制研究
- 批准号:82273767
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
MALDI质谱分析用于自身免疫性疾病的快速诊断筛查
- 批准号:22274160
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
糖表位相关自身免疫性疾病治疗新策略研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
自身免疫性疾病中RORγt 识别DNA调控转录的分子机制研究
- 批准号:2022JJ40763
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 45.75万 - 项目类别: